Free Internal Medicine CME

  • FREE

    Updates in Alzheimer Disease (AD) and Its Complications: Pharmacotherapy and Barriers to Optimal Care

    This free online CME course provides key insights around Alzheimer’s Disease (AD) and will lead to better understanding and treatment of the condition.

    Topics covered in this course include:

    • AD Treatment
    • AD Patient Cases
    • AD Clinical Pearls
    • ADPathophysiological process
    • Epidemiology

    After completing this course, you will better be able to:

    • Describe validated diagnostic and screening method(s) for AD and apply them to a patient case
    • Discuss the neuropathophysiology of AD and how it relates to presently available AD treatments’ mechanisms
    • List present and emerging pharmacotherapeutic therapies for the treatment of AD and its complications and apply them to patient cases, taking into account comorbid disease states and drug therapies
    • Describe the impact of medication adherence on patient outcomes and formulate strategies to improve adherence in patients with AD

    Target audience: Healthcare professionals specializing in: neurology, gerontology, internal medicine, palliative care, or those who otherwise commonly care for patients with AD or who frequently encounter them or their caregivers in practice.

    See full details chevron_right
    • Cost: Free
    • Credit hours: 1
    • CME credits awarded by: ScientiaCME
    • Format: On-Demand Online
    • Material last updated: July 07, 2018
    • Expiration of CME credit: July 07, 2020
  • FREE

    Hypoparathyroidism: therapeutic updates and optimizing treatment

    This free online CME course provides insights into Hypoparathyroidism and how to most effectively treat the condition.

    Topics covered in the course include:

    • Treatment of hypoparathyroidism
    • Barriers to optimal care
    • Hypoparathyroidism patient cases

    After completing thise course, you will better be able to:

    • Describe the pathophysiology and underlying etiologies of hypoparathyroidism and apply these to patient cases.
    • Describe the clinical manifestations of hypoparathyroidism and discuss how they may have relevance to treatment targets.
    • Identify available therapeutic options for hypoparathyroidism and incorporate these in the development of treatment plans in patient cases.
    • Define patient-specific goals related to the management of hypoparathyroidism.

    Target Audience: Endocrinologists and primary care physicians; physician assistants, nurse practitioners, nurses, and pharmacists who practice in endocrinology and internal medicine; and any other healthcare professionals with an interest in or who clinically encounter patients with hypoparathyroidism.

    See full details chevron_right
    • Cost: Free
    • Credit hours: 1
    • CME credits awarded by: ScientiaCME
    • Format: On-Demand Online
    • Material last updated: June 06, 2018
    • Expiration of CME credit: June 06, 2020
  • FREE

    Male Osteoporosis Management: Advances in Pharmacotherapy

    This free online CME program gives an in-depth look into male Osteoporosis and will help physicians treat this condition better among male patients.

    Topics covered in this course include:

    • Osteoperosis Epidemiology
    • Osteoperosis Risk factors
    • Guidance on screening criteria in men
    • Osteoperosis Treatment options

    After completing this program, you will better be able to:

    • Apply screening criteria for male osteoporosis to a given patient
    • Describe the criteria for initiation of pharmacotherapy for osteoporosis treatment and prevention and apply them to a patient case
    • Identify present pharmacotherapeutic treatments for management of male osteoporosis, and describe their mechanisms of action and place in therapy
    • Describe investigational pharmacotherapeutic treatments for management of male osteoporosis, and describe their mechanisms of action and likely place in therapy
    • Describe the challenges associated with treating patients with male osteoporosis, focus specifically on the risks (e.g., adverse drug reactions, drug interactions, et cetera) of the agents used to treat and prevent osteoporosis and apply the information in optimizing patient care in a patient case

    Target Audience: Primary care physicians and endocrinologists; physician assistants, nurse practitioners, nurses, and pharmacists who practice in endocrinology and internal medicine; and any other healthcare professionals with an interest in or who clinically encounter patients with male osteoporosis.

    See full details chevron_right
    • Cost: Free
    • Credit hours: 1
    • CME credits awarded by: ScientiaCME
    • Format: On-Demand Online
    • Material last updated: April 30, 2018
    • Expiration of CME credit: April 30, 2020
  • FREE

    CME: Hereditary angioedema (HAE): optimizing treatment strategies

    Hereditary angioedema (HAE) is a rare, debilitating, and potentially life-threatening disease due to C1-inhibitor (C1-INH) deficiency with an estimated frequency of 1 in 50,000 people. HAE is characterized by recurrent edema attacks and the cutaneous attacks can be disabling, with the skin, gastrointestinal tract, and upper airways are most commonly affected and with a persistent risk to the patient of acute events of laryngeal swelling that may prove fatal if not treated in a timely manner. Angioedema in general can be confused with cellulitis, Graves’ disease, blepharochalasis, eosinophilic fasciitis, or amyloidosis which can lead to delays in diagnosis, and inappropriate treatment poses the risk of adverse events, unnecessary surgical interventions, a higher burden of misery, and a potentially higher rate of morbidity and mortality.

    By the end of the session the participant will be able to:

    • Recall the pathophysiology of HAE such that it might inform treatment mechanisms
    • Recognize the risks associated with misdiagnosis of HAE
    • Evaluate a treatment plan for a patient with HAE designed to optimize safety and efficacy, suggesting modifications for improvement
    • Describe present and emerging drug therapies for management of HAE and apply them to patient cases taking into account the patient’s history or anticipated place in therapy

    Target Audience:

    Healthcare professionals who are: allergists, immunologists, and internists; physician assistants, nurse practitioners, nurses, and pharmacists specializing in immunology; and any other HCPs who have an interest in or otherwise clinically encounter patients with HAE.

    See full details chevron_right
    • Cost: Free
    • Credit hours: 1
    • CME credits awarded by: ScientiaCME
    • Format: On-Demand Online
    • Material last updated: 3/23/2020
    • Expiration of CME credit: 3/23/2022
  • FREE

    CME: Ulcerative Colitis: Updates from the DDW 2019 Annual Meeting

    IBD is a broad term that includes many different forms of inflammatory bowel conditions, the most common of which are ulcerative colitis (UC) and Crohn’s disease, the former of which exclusively affects the colon and rectum. Guidelines exist for the treatment of UC, but they are constantly changing to include updated information. Despite the plethora of guidelines available, there are issues surrounding guideline adherence by physicians, patient satisfaction, the quality of treatment and a patient’s QOL. Given the data from multiple studies that physicians are either not aware of updated practice guidelines or are not utilizing them, that this lack of knowledge is affecting patient satisfaction, and that there may be demographically-based barriers to care, educational activities are warranted to keep HCPs abreast of best practices in patients with UC. This activity has been designed to review treatment strategies, emerging therapies, and gaps in care of patients with UC.

    By the end of the session the participant will be able to:

    • Describe long-term outcomes of UC patients with dysplasia who undergo endoscopic resection and surveillance and apply that information to a patient case
    • Describe the effect of endoscopic and histologic remission as treatment targets
    • Describe the risk of biologic therapy use in special populations, such as elderly and surgical patients and apply that information to a patient case
    • Recall emerging data on biologic drug safety and efficacy

    Target Audience:

    Healthcare professionals specializing in: gastroenterology, internal medicine, and those who otherwise commonly care for patients with UC.

    See full details chevron_right
    • Cost: Free
    • Credit hours: 1
    • CME credits awarded by: ScientiaCME
    • Format: On-Demand Online
    • Material last updated: 9/23/19
    • Expiration of CME credit: 9/23/21
  • FREE

    CME: Prevention and management of influenza infection

    Influenza has been recognized as a global public health menace since at least 100 years ago with the 1918-19 pandemic, which infected an estimated one-third of the world’s population and was responsible for the deaths of one in ten, or 50 million, of those infected. While some have contended that a significant number of deaths associated with the 1918 pandemic may have actually been attributable to acid-base derangements and pulmonary edema associated with contemporary aspirin dosing in the toxic range of two to eight times what is presently the maximum recommended dose – it remains a significant public health concern, with the 2017-2018 flu season in recent decades with an estimated 80,000 deaths (typical range 12,000-56,000 per year),coming with an annual cost of $16 billion.

    By the end of the session the participant will be able to:

    • Determine the impact of influenza infection
    • Describe influenza vaccination recommendations and apply them to patient cases
    • Describe treatment recommendations and apply them to patient cases
    • Describe present challenges to the prevention and treatment of influenza and develop strategies to combat them

    Target Audience:

    Healthcare professionals specializing in: infectious disease, internal medicine, and pediatrics; physician assistants, nurse practitioners, nurses, and pharmacists who specialize in the aforementioned areas; and any other healthcare professionals with an interest in or who clinically encounter patients with influenza.

    See full details chevron_right
    • Cost: Free
    • Credit hours: 1
    • CME credits awarded by: ScientiaCME
    • Format: On-Demand Online
    • Material last updated: 7/23/19
    • Expiration of CME credit: 7/23/21